Matches in Wikidata for { <http://www.wikidata.org/entity/Q58212102> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q58212102 description "article scientifique publié en 2001" @default.
- Q58212102 description "im Januar 2001 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58212102 description "wetenschappelijk artikel" @default.
- Q58212102 description "наукова стаття, опублікована у 2001" @default.
- Q58212102 name "The angiogenic ?vascular endothelial growth factor/flk-1" @default.
- Q58212102 name "The angiogenic ?vascular endothelial growth factor/flk-1(KDR) receptor? pathway in patients with endometrial carcinoma" @default.
- Q58212102 type Item @default.
- Q58212102 label "The angiogenic ?vascular endothelial growth factor/flk-1" @default.
- Q58212102 label "The angiogenic ?vascular endothelial growth factor/flk-1(KDR) receptor? pathway in patients with endometrial carcinoma" @default.
- Q58212102 prefLabel "The angiogenic ?vascular endothelial growth factor/flk-1" @default.
- Q58212102 prefLabel "The angiogenic ?vascular endothelial growth factor/flk-1(KDR) receptor? pathway in patients with endometrial carcinoma" @default.
- Q58212102 P1433 Q58212102-EB89C964-4033-4F13-BA5A-B3C5237A4488 @default.
- Q58212102 P1476 Q58212102-47DC5475-71BA-45CC-8509-BA593CAD95DF @default.
- Q58212102 P2093 Q58212102-0883ECD7-D57B-4AFF-BB73-219B5CF78394 @default.
- Q58212102 P2093 Q58212102-186FFD91-420C-4E91-861E-1CF2C2BCDD09 @default.
- Q58212102 P2093 Q58212102-19E077F8-55AF-4F80-BBD3-620A4AE60E64 @default.
- Q58212102 P2093 Q58212102-19E65482-69A6-49BC-953C-DEAE227FCAC1 @default.
- Q58212102 P2093 Q58212102-1BCFEE0F-57FD-42B3-9A4F-0252272CD9DF @default.
- Q58212102 P2093 Q58212102-A86AB999-5B1E-40B9-90DF-E7C1E6AAFED2 @default.
- Q58212102 P2093 Q58212102-CDCA8E16-1416-4AD6-8C58-D44B04C6D075 @default.
- Q58212102 P304 Q58212102-4C58D922-54E2-41AD-8B8E-0802942410F3 @default.
- Q58212102 P31 Q58212102-4F7F0453-18F4-451F-BD62-F23584BDE19B @default.
- Q58212102 P356 Q58212102-A34A46D0-975E-45D4-A246-F2A289F91264 @default.
- Q58212102 P407 Q58212102-AC3C82A1-2A4D-488F-B650-59B047FBEE59 @default.
- Q58212102 P433 Q58212102-2FFD45CD-F6CE-4512-9E27-10FC560B30A5 @default.
- Q58212102 P478 Q58212102-28F3D9F0-AD12-4A8B-96EA-B7D4BF403EBE @default.
- Q58212102 P50 Q58212102-DC50E5EB-8042-474C-A037-AFF35DEF84DD @default.
- Q58212102 P577 Q58212102-0A577BED-29E4-4CF0-BB94-4FE3B5DBF3B8 @default.
- Q58212102 P921 Q58212102-3B6EC6DD-B29F-416A-8BB6-E4063A1593F3 @default.
- Q58212102 P921 Q58212102-69F01FA8-FD0C-47F0-8BDC-8ECF74D33ABC @default.
- Q58212102 P356 1097-0142(20011115)92:10%3C2569::AID-CNCR1609%3E3.0.CO;2-3 @default.
- Q58212102 P1433 Q326041 @default.
- Q58212102 P1476 "The angiogenic ?vascular endothelial growth factor/flk-1(KDR) receptor? pathway in patients with endometrial carcinoma" @default.
- Q58212102 P2093 "Alexandra Giatromanolaki" @default.
- Q58212102 P2093 "Efthimios Sivridis" @default.
- Q58212102 P2093 "Kevin C. Gatter" @default.
- Q58212102 P2093 "Michael I. Koukourakis" @default.
- Q58212102 P2093 "Panagiotis Anastasiadis" @default.
- Q58212102 P2093 "Philip E. Thorpe" @default.
- Q58212102 P2093 "Rolf Brekken" @default.
- Q58212102 P304 "2569-2577" @default.
- Q58212102 P31 Q13442814 @default.
- Q58212102 P356 "10.1002/1097-0142(20011115)92:10<2569::AID-CNCR1609>3.0.CO;2-3" @default.
- Q58212102 P407 Q1860 @default.
- Q58212102 P433 "10" @default.
- Q58212102 P478 "92" @default.
- Q58212102 P50 Q37374768 @default.
- Q58212102 P577 "2001-01-01T00:00:00Z" @default.
- Q58212102 P921 Q18555222 @default.
- Q58212102 P921 Q3421914 @default.